Dual Bronchodilator Therapy with Umeclidinium/Vilanterol Versus Tiotropium plus Indacaterol in Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial

por Kalberg, Chris, O’Dell, Dianne, Galkin, Dmitry, Newlands, Amy, Fahy, William A.
Publicado 2016

A randomised, open-label study of umeclidinium versus glycopyrronium in patients with COPD

por Rheault, Tara, Khindri, Sanjeev, Vahdati-Bolouri, Mitra, Church, Alison, Fahy, William A.
Publicado 2016

A randomized, parallel-group study to evaluate the efficacy of umeclidinium/vilanterol 62.5/25 μg on health-related quality of life in patients with COPD

por Siler, Thomas M, Donald, Alison C, O’Dell, Dianne, Church, Alison, Fahy, William A
Publicado 2016

Terms and Definitions Used to Describe Recurrence, Treatment Failure and Recovery of Acute Exacerbations of COPD: A Systematic Review of Observational Studies

por Meeraus, Wilhelmine H, DeBarmore, Bailey M, Mullerova, Hana, Fahy, William A, Benson, Victoria S
Publicado 2021

Prevention of clinically important deteriorations in COPD with umeclidinium/vilanterol

por Singh, Dave, Maleki-Yazdi, M Reza, Tombs, Lee, Iqbal, Ahmar, Fahy, William A, Naya, Ian
Publicado 2016

Assessing Short-term Deterioration in Maintenance-naïve Patients with COPD Receiving Umeclidinium/Vilanterol and Tiotropium: A Pooled Analysis of Three Randomized Trials

por Maleki-Yazdi, M. Reza, Singh, Dave, Anzueto, Antonio, Tombs, Lee, Fahy, William A., Naya, Ian
Publicado 2016

A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 μg compared with tiotropium 18 μg in patients with COPD

por Feldman, Gregory, Maltais, François, Khindri, Sanjeev, Vahdati-Bolouri, Mitra, Church, Alison, Fahy, William A, Trivedi, Roopa
Publicado 2016

The effect of umeclidinium added to inhaled corticosteroid/long-acting β(2)-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group study

por Sousa, Ana R, Riley, John H, Church, Alison, Zhu, Chang-Qing, Punekar, Yogesh S, Fahy, William A
Publicado 2016

Predicting Re-Exacerbation Timing and Understanding Prolonged Exacerbations: An Analysis of Patients with COPD in the ECLIPSE Cohort

por Meeraus, Wilhelmine H, Mullerova, Hana, El Baou, Céline, Fahey, Marion, Hessel, Edith M, Fahy, William A
Publicado 2021

Relationship between exercise endurance and static hyperinflation in a post hoc analysis of two clinical trials in patients with COPD

por Singh, Sally, Maltais, François, Tombs, Lee, Fahy, William A, Vahdati-Bolouri, Mitra, Locantore, Nicholas, Riley, John H
Publicado 2018

Umeclidinium/vilanterol as step-up therapy from tiotropium in patients with moderate COPD: a randomized, parallel-group, 12-week study

por Kerwin, Edward M, Kalberg, Chris J, Galkin, Dmitry V, Zhu, Chang-Qing, Church, Alison, Riley, John H, Fahy, William A
Publicado 2017

Volcanic ash ice nucleation activity is variably reduced by aging in water and sulfuric acid: the effects of leaching, dissolution, and precipitation

por Fahy, William D., Maters, Elena C., Giese Miranda, Rona, Adams, Michael P., Jahn, Leif G., Sullivan, Ryan C., Murray, Benjamin J.
Publicado 2021

The topical study of inhaled drug (salbutamol) delivery in idiopathic pulmonary fibrosis

por Usmani, Omar S., Biddiscombe, Martyn F., Yang, Shuying, Meah, Sally, Oballa, Eunice, Simpson, Juliet K., Fahy, William A., Marshall, Richard P., Lukey, Pauline T., Maher, Toby M.
Publicado 2018

Circulating fibrocytes are not disease-specific prognosticators in idiopathic pulmonary fibrosis

por Stewart, Iain D., Nanji, Henry, Figueredo, Grazziela, Fahy, William A., Maher, Toby M., Ask, Antje J., Maharaj, Shyam, Ask, Kjetil, Kolb, Martin, Jenkins, Gisli R.
Publicado 2021

Atmospheric aging enhances the ice nucleation ability of biomass-burning aerosol

por Jahl, Lydia G., Brubaker, Thomas A., Polen, Michael J., Jahn, Leif G., Cain, Kerrigan P., Bowers, Bailey B., Fahy, William D., Graves, Sara, Sullivan, Ryan C.
Publicado 2021

Nemiralisib in Patients with an Acute Exacerbation of COPD: Placebo-Controlled, Dose-Ranging Study

por Fahy, William A, Homayoun-Valiani, Farshid, Cahn, Anthony, Robertson, Jon, Templeton, Alison, Meeraus, Wilhelmine H, Wilson, Robert, Lowings, Mike, Marotti, Miriam, West, Sarah L, Tabberer, Maggie, Hessel, Edith M
Publicado 2021

Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin αvβ6 inhibitor, in healthy participants

por Maden, Charlotte H., Fairman, David, Chalker, Michelle, Costa, Maria J., Fahy, William A., Garman, Nadia, Lukey, Pauline T., Mant, Tim, Parry, Simon, Simpson, Juliet K., Slack, Robert J., Kendrick, Stuart, Marshall, Richard P.
Publicado 2018

Cluster analysis of transcriptomic datasets to identify endotypes of idiopathic pulmonary fibrosis

por Kraven, Luke M, Taylor, Adam R, Molyneaux, Philip L, Maher, Toby M, McDonough, John E, Mura, Marco, Yang, Ivana V, Schwartz, David A, Huang, Yong, Noth, Imre, Ma, Shwu Fan, Yeo, Astrid J, Fahy, William A, Jenkins, R Gisli, Wain, Louise V
Publicado 2023

Clinical quantification of the integrin αvβ6 by [(18)F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study)

por Lukey, Pauline T., Coello, Christopher, Gunn, Roger, Parker, Christine, Wilson, Frederick J., Saleem, Azeem, Garman, Nadia, Costa, Maria, Kendrick, Stuart, Onega, Mayca, Kang’ombe, Arthur R., Listanco, Allan, Davies, James, Ramada-Magalhaes, Joaquim, Moz, Sara, Fahy, William A., Maher, Toby M., Jenkins, Gisli, Passchier, Jan, Marshall, Richard P.
Publicado 2019

Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren’s syndrome

por Nayar, Saba, Campos, Joana, Smith, Charlotte G, Iannizzotto, Valentina, Gardner, David H, Colafrancesco, Serena, Pipi, Elena, Kollert, Florian, Hunter, Kelly J, Brewer, Charlotte, Buckley, Christopher Dominic, Bowman, Simon J, Priori, Roberta, Valesini, Guido, Juarez, Maria, Fahy, William A, Fisher, Benjamin A, Payne, Andrew, Allen, Rodger A, Barone, Francesca
Publicado 2019